SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-15-005258
Filing Date
2015-06-23
Accepted
2015-06-23 08:15:31
Documents
4
Period of Report
2015-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1501470_8k.htm 8-K 46986
2 EXHIBIT 10.1 t1501470_ex10-1.htm EX-10.1 1910268
3 EXHIBIT 99.2 t1501470_ex99-2.htm EX-99.2 18116
4 GRAPHIC image_001.jpg GRAPHIC 11179
  Complete submission text file 0001571049-15-005258.txt   1992464
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 15946088
SIC: 2834 Pharmaceutical Preparations